NCT04945408View on ClinicalTrials.gov

Longitudinal Description of Hemorrhoidal Pathology

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

March 6, 2023

Conditions

Hemorrhoids

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors

lead

Fondation Hôpital Saint-Joseph

OTHER

NCT04945408 - Longitudinal Description of Hemorrhoidal Pathology | Biotech Hunter | Biotech Hunter